Hindustan Bio Sciences Limited (BOM:532041)
India · Delayed Price · Currency is INR 6.17
-0.05 (-0.80%)
At close: Jan 20, 2026
Hindustan Bio Sciences Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 7.24 | 8.13 | 10.53 | 9.22 | 4.31 | 10.32 | Upgrade |
Other Revenue | 0.07 | - | - | - | - | - | Upgrade |
| 7.32 | 8.13 | 10.53 | 9.22 | 4.31 | 10.32 | Upgrade | |
Revenue Growth (YoY) | -36.44% | -22.75% | 14.15% | 114.19% | -58.27% | -46.90% | Upgrade |
Cost of Revenue | 4.52 | 4.97 | 6.44 | 5.79 | 2.48 | 6.92 | Upgrade |
Gross Profit | 2.8 | 3.16 | 4.09 | 3.44 | 1.82 | 3.4 | Upgrade |
Selling, General & Admin | 1.59 | 1.32 | 1.65 | 2.62 | 2.53 | 2.58 | Upgrade |
Other Operating Expenses | 0.95 | 0.84 | 1.8 | 1.1 | 4.31 | 10.14 | Upgrade |
Operating Expenses | 2.57 | 2.17 | 3.52 | 3.77 | 6.87 | 12.8 | Upgrade |
Operating Income | 0.23 | 1 | 0.57 | -0.34 | -5.05 | -9.4 | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | - | -0.05 | -0.09 | Upgrade |
Other Non Operating Income (Expenses) | -0.01 | -0.02 | -0.04 | -0.04 | -0.05 | -0.07 | Upgrade |
EBT Excluding Unusual Items | 0.22 | 0.98 | 0.53 | -0.38 | -5.14 | -9.55 | Upgrade |
Pretax Income | 0.22 | 0.98 | 0.53 | -0.38 | -5.14 | -9.55 | Upgrade |
Income Tax Expense | -0.03 | -0.03 | -0.04 | 0.03 | 0.03 | -0.15 | Upgrade |
Net Income | 0.25 | 1.01 | 0.58 | -0.4 | -5.18 | -9.4 | Upgrade |
Net Income to Common | 0.25 | 1.01 | 0.58 | -0.4 | -5.18 | -9.4 | Upgrade |
Net Income Growth | -83.06% | 74.83% | - | - | - | - | Upgrade |
Shares Outstanding (Basic) | 11 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Shares Outstanding (Diluted) | 11 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Shares Change (YoY) | 6.34% | - | - | - | - | - | Upgrade |
EPS (Basic) | 0.02 | 0.10 | 0.06 | -0.04 | -0.50 | -0.92 | Upgrade |
EPS (Diluted) | 0.02 | 0.10 | 0.06 | -0.04 | -0.50 | -0.92 | Upgrade |
EPS Growth | -84.07% | 74.83% | - | - | - | - | Upgrade |
Free Cash Flow | -4.56 | 0.27 | -14.09 | -0.5 | -3.46 | 7.53 | Upgrade |
Free Cash Flow Per Share | -0.43 | 0.03 | -1.38 | -0.05 | -0.34 | 0.73 | Upgrade |
Gross Margin | 38.24% | 38.89% | 38.84% | 37.26% | 42.33% | 32.94% | Upgrade |
Operating Margin | 3.17% | 12.25% | 5.42% | -3.67% | -117.17% | -91.08% | Upgrade |
Profit Margin | 3.36% | 12.38% | 5.47% | -4.39% | -120.19% | -91.08% | Upgrade |
Free Cash Flow Margin | -62.27% | 3.33% | -133.83% | -5.40% | -80.41% | 72.97% | Upgrade |
EBITDA | 0.27 | 1 | 0.64 | -0.28 | -5.01 | -9.32 | Upgrade |
EBITDA Margin | 3.65% | 12.27% | 6.07% | -3.06% | -116.38% | -90.30% | Upgrade |
D&A For EBITDA | 0.04 | 0 | 0.07 | 0.06 | 0.03 | 0.08 | Upgrade |
EBIT | 0.23 | 1 | 0.57 | -0.34 | -5.05 | -9.4 | Upgrade |
EBIT Margin | 3.17% | 12.25% | 5.42% | -3.67% | -117.17% | -91.08% | Upgrade |
Revenue as Reported | 7.32 | 8.13 | 10.53 | 9.22 | 4.31 | 10.32 | Upgrade |
Advertising Expenses | - | 0.05 | 0.07 | 0.07 | 0.06 | 0.05 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.